Company: CWAN
Filing Date: 2025-02-11
Form Type: S-4
Source: 0001193125-25-023759
Chunk: 237

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-02-11
Form: S-4
Chunk 237
---
 2024. Consists                                                                                                                                            
 of (a) 1,184,271 shares of Enfusion Common Stock and (b) 5,000,000 shares of Enfusion Common Stock that LRA Ventures, LLC (“LRA Ventures”) has the right to acquire upon the exchange of Common Units. Tarek Hammoud is the sole manager             
 of LRA Ventures and may be deemed the beneficial owner of such 1,184,271 shares of Enfusion Common Stock directly held by LRA Ventures and 5,000,000 shares of Enfusion Common Stock that LRA Ventures has the right to acquire upon the exchange of 
 Common Units by virtue of his position as the control person of LRA Ventures. The address for each of LRA Ventures and Tarek Hammoud is 4701 North Meridian Ave, Unit UPH12, Miami Beach, FL 33140.                                                  |

168

| (11) | Based solely on information provided in a Schedule 13G/A filed with the SEC on January 31, 2025. Consists                                                                                                                                               
 of 6,870,386 shares of Enfusion Common Stock that Malherbe Investments LLC has the right to acquire upon the exchange of Common Units. Mr. Malherbe is the beneficial owner of 100% of the voting interests of Malherbe Investments LLC and is the      
 sole manager, and may be deemed the beneficial owner of such 6,870,386 shares that Malherbe Investments LLC has the right to acquire upon the exchange of Common Units by virtue of his position as the control person of Malherbe Investments LLC. The 
 address for each of Malherbe Investments LLC and Stephen Malherbe is 1063 Gallant Court, Wheaton, Illinois 60187.                                                                                                                                       |

| (12) | Based solely on information provided in a Schedule 13G filed with the SEC on February 14, 2022 by                                                                                                                                                       
 Hillhouse Investment Management, Ltd. (“HIM”), with respect to the shares of Enfusion Common Stock held by ELL Investments, L.P. (“ELL”). ELL is wholly owned by Hillhouse Fund IV, L.P. (“Fund IV”).                                                   
 HIM acts as the sole management company of Fund IV. HIM has sole voting and dispositive power over the 4,975,183 shares of Enfusion Common Stock and may be deemed the beneficial owner of such shares. The address of Hillhouse Investment Management, 
 Ltd. is Office #122, Wind